Non-Steroidal Anti-inflammatory Drugs Market Outlook 2026–2035: Growth Drivers and Industry Forecast
Uncover key drivers, emerging technologies, and competitive movements shaping the non-steroidal anti-inflammatory drugs market from 2026–2035 with trusted insights from The Business Research Company
Across 2026–2030, what is the expected market valuation path of the Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market has experienced significant growth in recent years. It is projected to expand from $21.89 billion in 2025 to $23.31 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.5%. Historically, this expansion is attributable to factors such as the increasing prevalence of arthritis and musculoskeletal disorders, a rising awareness of pain management therapies, the growth in the geriatric population, the expansion of retail pharmacies, and advancements in drug formulation technologies.
The non-steroidal anti-inflammatory drugs market size is projected to experience substantial expansion in the coming years. This market is set to reach $29.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. The anticipated growth during this period stems from factors such as the increasing adoption of personalized medicine, the expansion of e-pharmacy platforms, enhanced research and development in new NSAID formulations, a growing prevalence of chronic inflammatory diseases, and the incorporation of digital health solutions for pain surveillance. Key developments expected during the forecast period include the emergence of personalized pain management approaches, an escalating demand for over-the-counter anti-inflammatory medications, the creation of fast-acting formulations, a greater emphasis on managing chronic pain and arthritis, and the broadening reach of online pharmacy networks.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
Which Drivers Are Supporting The Rise Of The Non-Steroidal Anti-inflammatory Drugs Market?
The increasing prevalence of musculoskeletal disorders is expected to propel the growth of the non-steroidal anti-inflammatory drug market going forward. Musculoskeletal disorders (MSDs) encompass a wide array of conditions affecting the musculoskeletal system, including muscles, bones, tendons, ligaments, joints, and other connective tissues. Non-steroidal anti-inflammatory drugs (NSAIDs) play a crucial role in managing pain and inflammation linked to conditions such as arthritis, osteoarthritis, and rheumatoid arthritis. Factors contributing to this market expansion include the aging population, enhanced awareness and diagnosis of musculoskeletal disorders, orthopedic procedures, sports injuries, and the chronic nature of these conditions. For instance, in January 2024, according to GOV.UK, a UK-based government department, 18.4% of individuals aged 16 and older reported having a long-term musculoskeletal (MSK) condition in 2023, marking an increase from the 17.6% prevalence recorded in 2022. Therefore, the rise in the prevalence of musculoskeletal disorders is driving the growth of the non-steroidal anti-inflammatory drugs market.
What Segments Are Identified Within The Structure Of The Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented –
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
What Trends Are Projected To Support The Growth Of The Non-Steroidal Anti-inflammatory Drugs Market?
Leading companies operating in the non-steroidal anti-inflammatory drugs (NSAIDs) market are concentrating on developing innovative solutions, such as combination analgesic–gastroprotective formulations. This effort aims to satisfy the increasing need for potent pain relief while lessening the gastrointestinal dangers frequently linked to extended NSAID consumption. These combined technologies integrate an NSAID with a protective component, ensuring continued anti-inflammatory effectiveness and guarding against gastric irritation, thereby presenting a more secure option compared to conventional single-agent NSAIDs. A notable example is the March 2024 release by Endo International plc, an Irish pharmaceutical firm, of ibuprofen-famotidine 800 mg/26.6 mg tablets. This advanced preparation integrates ibuprofen’s pain-relieving and anti-inflammatory properties with famotidine’s gastroprotective capabilities. This tablet, featuring a dual mechanism, is engineered to alleviate pain and simultaneously reduce gastrointestinal adverse effects, including ulcers or irritation, which are frequent complications of extended NSAID treatment, ultimately boosting safety and enhancing patient compliance.
Which Key Market Players Are Investing In Expansion And Innovation Within The Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company
Access The Complete Report For Deeper Market Insights:
Which Regions Are Poised For Strategic Growth In The Non-Steroidal Anti-inflammatory Drugs Market?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Non-Steroidal Anti-inflammatory Drugs Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp
Browse Through More Reports Similar to the Global Non-Steroidal Anti-inflammatory Drugs Market 2026, By The Business Research Company
Non Steroidal Anti Inflammatory Drugs Market Report 2026
Anti Inflammatory Therapeutics Market Report 2026
Rheumatoid Arthritis Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
